Latest Commercial Partnerships News

SportsHero has officially launched its HeroPlay mobile gaming platform in Indonesia through a partnership with Indosat Ooredoo Hutchison, offering over 600 instantly playable HTML5 games to nearly 99 million potential users.

Li-S Energy has accelerated its transition from research to manufacturing with a $7.8 million ARENA grant, new commercial partnerships, and plans for a large-scale production facility.

Dotz Nano has successfully scaled up production of its proprietary CO₂ capture sorbents to kilogram volumes, setting the stage for commercial partnerships and cost efficiencies in the growing carbon capture market.

Ovanti Limited has made significant strides in its U.S. buy now, pay later (BNPL) expansion, securing a major partnership with Shift4 Payments and raising $8 million to fuel growth.

BPH Global Limited secured $1.1 million in a recent placement and reported robust growth in its Indonesian seaweed operations, alongside promising advances in innovative seaweed-based products and strategic regional partnerships.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

I Synergy Group Limited reported a mixed quarterly cash flow for Q3 2025, highlighting ongoing operational cash outflows but securing financing to extend its runway to just under two quarters.

4DMedical Limited has secured FDA clearance and immediate Medicare reimbursement for its groundbreaking CT – VQ™ lung imaging technology, accelerating commercial adoption across the US, Brazil, and Australia.

Decidr AI Industries moves to acquire full ownership of Decidr.ai, launches its unified AI platform DecidrOS, and reports robust Q1 FY26 progress with significant capital raising and expanding partnerships.

Sparc Technologies has completed construction of a pioneering green hydrogen pilot plant and secured new patents, while its graphene additive trials show promising corrosion resistance results.

Amplia Therapeutics reports encouraging interim results for narmafotinib in metastatic pancreatic cancer, alongside a successful capital raise and key patent allowance.

dorsaVi reports breakthrough RRAM sensor performance and secures a major US physical therapy deal, backed by a $5 million capital raise and new leadership appointments.